HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms.

AbstractBACKGROUND:
Thyroid receptors, TRalpha and TRbeta, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRbeta isoform activation, TRalpha activation affects heart rates. Therefore, beta-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor(c)) in studies in rats, mice and monkeys.
RESULTS:
To investigate GC-1 specificity, we solved crystal structures and performed molecular dynamics simulations of both isoforms complexed with GC-1. Crystal structures reveal that, in TRalpha Arg228 is observed in multiple conformations, an effect triggered by the differences in the interactions between GC-1 and Ser277 or the corresponding asparagine (Asn331) of TRbeta. The corresponding Arg282 of TRbeta is observed in only one single stable conformation, interacting effectively with the ligand. Molecular dynamics support this model: our simulations show that the multiple conformations can be observed for the Arg228 in TRalpha, in which the ligand interacts either strongly with the ligand or with the Ser277 residue. In contrast, a single stable Arg282 conformation is observed for TRbeta, in which it strongly interacts with both GC-1 and the Asn331.
CONCLUSION:
Our analysis suggests that the key factors for GC-1 selectivity are the presence of an oxyacetic acid ester oxygen and the absence of the amino group relative to T3. These results shed light into the beta-selectivity of GC-1 and may assist the development of new compounds with potential as drug candidates to the treatment of hypercholesterolemia and obesity.
AuthorsLucas Bleicher, Ricardo Aparicio, Fabio M Nunes, Leandro Martinez, Sandra M Gomes Dias, Ana Carolina Migliorini Figueira, Maria Auxiliadora Morim Santos, Walter H Venturelli, Rosangela da Silva, Paulo Marcos Donate, Francisco Ar Neves, Luiz A Simeoni, John D Baxter, Paul Webb, Munir S Skaf, Igor Polikarpov
JournalBMC structural biology (BMC Struct Biol) Vol. 8 Pg. 8 ( 2008) ISSN: 1472-6807 [Electronic] England
PMID18237438 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • GC 1 compound
  • Ligands
  • Phenols
  • Protein Isoforms
  • Thyroid Hormone Receptors alpha
  • Thyroid Hormone Receptors beta
Topics
  • Acetates (chemistry, metabolism)
  • Binding Sites
  • Computer Simulation
  • Crystallography, X-Ray
  • HeLa Cells
  • Humans
  • Ligands
  • Models, Biological
  • Phenols (chemistry, metabolism)
  • Protein Isoforms (chemistry, metabolism)
  • Thyroid Hormone Receptors alpha (chemistry, metabolism)
  • Thyroid Hormone Receptors beta (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: